The regulatory demands of advanced therapeutics manufacturing differ significantly from conventional pharmaceutical manufacturing. With the ever-increasing focus on patient safety and product quality by the FDA, it is imperative that biomanufacturers embrace digital solutions to comply with regulations and avoid warning letters.
Join Honeywell to learn more from Dr. Arshad Azwad on how biomanufacturing companies are leveraging digital systems to navigate these challenges.
![]() |
Arshad Azwad
Biomanufacturing Specialist
Speaker Bio: Arshad Azwad, Ph.D., is the Biomanufacturing Specialist for the Life Sciences vertical within Honeywell Process Solutions, responsible for identifying customer pain points and providing tailored solutions for different types of modality manufacturing (ranging from small molecule to cell & gene therapy). Arshad holds a PhD in Biopharmaceutical Technology from the National University of Singapore and an MBA from Cornell University.
|
![]() |
Firstname
Title
Speaker Bio:Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
|
|
Speaker Bio:
|
|
Speaker Bio:
|
|
Speaker Bio:
|
|
Speaker Bio:
|
|
Speaker Bio:
|
|
Speaker Bio:
|